Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of molecular and clinical variables on survival outcome with immunotherapy for glioblastoma patients: A systematic review and meta-analysis. | CNS Neurosci Ther | 2022 | 35822692 | PubTator, text mining | PubMed |
| The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer. | Mil Med Res | 2022 | 35820970 | PubTator, text mining | PubMed |
| The human amniotic epithelium confers a bias to differentiate toward the neuroectoderm lineage in human embryonic stem cells. | Elife | 2022 | 35815953 | PubTator, text mining | PubMed |
| Altered Levels of Negative Costimulatory Molecule V-Set Domain-Containing T-Cell Activation Inhibitor-1 (VTCN1) and Metalloprotease Nardilysin (NRD1) are Associated with Generalized Active Vitiligo. | Immunol Invest | 2022 | 35815687 | PubTator, text mining | PubMed |
| Integrative Analyses of m6A Regulators Identify that METTL3 is Associated with HPV Status and Immunosuppressive Microenvironment in HPV-related Cancers. | Int J Biol Sci | 2022 | 35813476 | PubTator, text mining | PubMed |
| The Role of P4HA1 in Multiple Cancer Types and its Potential as a Target in Renal Cell Carcinoma. | Front Genet | 2022 | 35812752 | PubTator, text mining | PubMed |
| The Role of the Immune System in the Development of Endometriosis. | Cells | 2022 | 35805112 | PubTator, text mining | PubMed |
| Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer. | Medicine (Baltimore) | 2022 | 35801800 | PubTator, text mining | PubMed |
| Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer. | Oncoimmunology | 2022 | 35800156 | PubTator, text mining | PubMed |
| eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma. | J Transl Med | 2022 | 35794622 | PubTator, text mining | PubMed |
| Co-Inhibitory Molecules - Their Role in Health and Autoimmunity; Highlighted by Immune Related Adverse Events. | Front Immunol | 2022 | 35784333 | PubTator, text mining | PubMed |
| The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes. | Front Immunol | 2022 | 35784290 | PubTator, text mining | PubMed |
| The Role of Hysterectomy in Modern Gynaecological Surgery. | Biomed Res Int | 2022 | 35782083 | PubTator, text mining | PubMed |
| Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods. | Comput Math Methods Med | 2022 | 35774297 | PubTator, text mining | PubMed |
| Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial Cancer. | Biomed Res Int | 2022 | 35774278 | PubTator, text mining | PubMed |
| Characterizing HDAC Pathway Copy Number Variation in Pan-Cancer. | Pathol Oncol Res | 2022 | 35769830 | PubTator, text mining | PubMed |
| The Coexpression and Clinical Significance of Costimulatory Molecules B7-H1, B7-H3, and B7-H4 in Human Pancreatic Cancer [Retraction]. | Onco Targets Ther | 2022 | 35769125 | PubTator, text mining | PubMed |
| A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma. | Front Oncol | 2022 | 35756689 | PubTator, text mining | PubMed |
| Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. | Pharmaceutics | 2022 | 35745815 | PubTator, text mining | PubMed |
| Placental Syndromes-A New Paradigm in Perinatology. | Int J Environ Res Public Health | 2022 | 35742640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=40